{
    "2018-08-27": [
        [
            {
                "time": "2018-08-27",
                "original_text": "众生药业：与上海药明康德共同研发的创新药获批临床试验",
                "features": {
                    "keywords": [
                        "众生药业",
                        "药明康德",
                        "创新药",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "医药行业周报：中报业绩持续造好，反弹有望延续",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报业绩",
                        "反弹",
                        "延续"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "药明康德A股上市后首份中报，收入利润保持稳健增长态势",
                "features": {
                    "keywords": [
                        "药明康德",
                        "中报",
                        "收入利润",
                        "稳健增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "业绩成长吸引投资者，社保基金与QFII同持56股",
                "features": {
                    "keywords": [
                        "业绩成长",
                        "投资者",
                        "社保基金",
                        "QFII"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-27",
                "original_text": "业绩成长吸引机构投资者目光，社保基金与QFII同持56股",
                "features": {
                    "keywords": [
                        "业绩成长",
                        "机构投资者",
                        "社保基金",
                        "QFII"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}